$0.1472
-0.00640-4.17%
At close: -
$0.1431
-0.00410-2.79%
After Hours: 7:38 PM EDT
AIM ImmunoTech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AIM ImmunoTech using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-15 | $-0.06 | $-0.09 | 33.3 % |
Q2 | 2024-08-14 | $-0.03 | $-0.12 | 75.0 % |
Q1 | 2024-05-16 | $-0.12 | $-0.11 | -9.09 % |
Q4 | 2024-04-02 | $-0.26 | $-0.15 | -73.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-15 | $35.00K | $11.67K | 199.9 % |
Q2 | 2024-08-14 | $50.00K | $10.00K | 400.0 % |
Q4 | 2024-04-02 | $65.00K | $40.00K | 62.5 % |
Q3 | 2023-11-14 | $46.00K | $20.00K | 130.0 % |
AIM ImmunoTech (AIM) is scheduled to report earnings on April 1, 2025. The last reported earnings were for reported on November 15, 2024 for Q3.
The Actual EPS was $-0.06, which beat the estimate of $-0.09.
The Actual Revenue was $35K, which beat the estimate of $11.7K.
Browse earnings estimates, EPS, and revenue on all stocks.